ÀÎÅÍ·çŲ-2¸¦ »ç¿ëÇÑ ¿äµµ ³» ÷±Ô Äܵô·Î¸¶ Ä¡·á
Treatment of Urethral Condyloma by Interleukin-2
Á¤¿ø¼®, ¹Ú°æ±â, ±è¿µ½Ä, À̼®¿µ, °í¿ìÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤¿ø¼® ( Jung Won-Sug )
±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø ºñ´¢±â°úÇб³½Ç
¹Ú°æ±â ( Park Kyung-Kgi )
±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø ºñ´¢±â°úÇб³½Ç
±è¿µ½Ä ( Kim Young-Sig )
±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø ºñ´¢±â°úÇб³½Ç
À̼®¿µ ( Lee Suk-Young )
±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø ºñ´¢±â°úÇб³½Ç
°í¿ìÁø ( Ko Woo-Jin )
±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø ºñ´¢±â°úÇб³½Ç
KMID : 0358320080490070653
Abstract
We report two patients with relapsed urethral condyloma treated by interleukin-2(IL-2) instillation. The patients had undergone prior treatment of the urethral condyloma; however, all patients had recurrent disease within one year of the primary treatment. We performed repeated transurethral resection of the urethra. However, the mass was incompletely resected due to its multiplicity and concerns about urethral injury. After surgery, IL-2(18x106IU) mixed with 1.2ml of distilled water was equally divided into six units(3x106IU); 10ml of distilled water was mixed with each unit. The solution was then administered into the urethra. After 6 days of the IL-2 intraurethral treatment, no visible warts were noted. No recurrence has been observed in over 1 year of follow up.
Å°¿öµå
Condylomata acuminata;Interleukin-2
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸